Memantine Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Memantine Hydrochloride
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Memantine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

98 API Suppliers, 33 USDMF, 10 JDMF, 14 EU WC, 28 KDMF, 31 NDC API, 43 Listed Suppliers, $ API Reference Price

98 API Suppliers
33 USDMF
10 JDMF
14 EU WC
28 KDMF
31 NDC API
43 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

37 Drugs in Development

37 Drugs in Development

INTERMEDIATES

14 Intermediate Suppliers

14 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

489 FDF Dossiers, 128 FDA Orange Book, 244 Europe, 12 Canada, 14 Australia, 8 South Africa, 83 Listed Dossiers

489 FDF Dossiers
128 FDA Orange Book
244 Europe
12 Canada
14 Australia
8 South Africa
83 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 5MG, CAPSULE, EXTENDED RELEASE;ORAL - 14MG, CAPSULE, EXTENDED RELEASE;ORAL - 21MG, CAPSULE, EXTENDED RELEASE;ORAL - 28MG, CAPSULE, EXTENDED RELEASE;ORAL - 7MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG
TABLET;ORAL - 5MG
CAPSULE, EXTENDED RELEASE;ORAL - 14MG
CAPSULE, EXTENDED RELEASE;ORAL - 21MG
CAPSULE, EXTENDED RELEASE;ORAL - 28MG
CAPSULE, EXTENDED RELEASE;ORAL - 7MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 2 Rochem International Inc, 8 SPI Pharma, 11 DKSH, 1 Pharm-RX Chemical, 5 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 4 Kirsch Pharma, 4 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 Avesta Pharma, 26 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 9 Gangwal Chemicals, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 25 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 27 Roquette, 8 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

70 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 32 Thickeners and Stabilizers, 31 Granulation, 31 Direct Compression, 31 Controlled & Modified Release, 30 Disintegrants & Superdisintegrants, 25 Film Formers & Plasticizers, 24 Lubricants & Glidants, 21 Topical, 20 Taste Masking, 19 Solubilizers, 18 Parenteral, 13 Co-Processed Excipients, 10 Chewable & Orodispersible Aids, 9 Empty Capsules, 7 Emulsifying Agents, 7 Rheology Modifiers, 6 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 1 Soft Gelatin

70 Fillers, Diluents & Binders
54 Coating Systems & Additives
32 Thickeners and Stabilizers
31 Granulation
31 Direct Compression
31 Controlled & Modified Release
30 Disintegrants & Superdisintegrants
25 Film Formers & Plasticizers
24 Lubricants & Glidants
21 Topical
20 Taste Masking
19 Solubilizers
18 Parenteral
13 Co-Processed Excipients
10 Chewable & Orodispersible Aids
9 Empty Capsules
7 Emulsifying Agents
7 Rheology Modifiers
6 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 86 News #PharmaBuzz

1 Data Compilation #PharmaFlow
86 News #PharmaBuzz

GLOBAL SALES INFORMATION

34 US Medicaid Prescriptions, 174 Regulatory FDF Prices, 12 Annual Reports

34 US Medicaid Prescriptions
174 Regulatory FDF Prices
12 Annual Reports

MARKET PLACE

16 APIs, 5 FDF Dossiers

16 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

48 US Patents, 2 US Exclusivities, 1 Health Canada Patents

48 US Patents
2 US Exclusivities
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 23 Others

1 USP
23 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 519 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Lundbeck Canada Inc.

filter Patent Reset all filters

1 All

01 12426492

filter Product Reset all filters

1 All

01 1Memantine Hydrochloride

filter Dosage Reset all filters

1 All

01 1Tablet

filter Exp Date Reset all filters

1 All

01 12023-05-08

Memantine Hydrochloride

Product Main Page

01

Lundbeck Canada Inc.

Memantine Hydrochloride

Coatings Trends

Not Confirmed

Lundbeck Canada Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-05-08

Date Granted : 2006-10-03

Memantine Hydrochloride

Brand Name : EBIXA

Patent Number : 2426492

Filing Date : 2003-05-08

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-05-08

Date Granted : 2006-10-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!